Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Med Case Rep ; 13(1): 73, 2019 Mar 10.
Article in English | MEDLINE | ID: mdl-30851737

ABSTRACT

BACKGROUND: A giant congenital cervical teratoma is often highly vascularized; thus, in addition to a life-threatening airway occlusion at birth it comprises a high risk for significant and lethal blood loss during resection. In the case presented, an endovascular embolization of the carotid artery that supplied a giant congenital cervical teratoma was done as part of a three-stage treatment soon after birth and contributed to an overall good outcome. Embolization in cases of cervical teratomas was not described previously. CASE PRESENTATION: We present a case of a preterm newborn from a Sephardic jewish origin with a giant, highly vascularized, congenital cervical teratoma that was managed successfully in three stages: (1) delivery by an ex utero intrapartum treatment procedure after extensive preoperative planning and followed by tracheostomy, (2) endovascular embolization of the carotid artery that supplied the tumor in order to decrease blood loss during resection, and (3) complete surgical resection. The parents were involved in all the ethical and medical decisions, starting just after the cervical mass was diagnosed prenatally. CONCLUSION: The management of giant congenital cervical teratoma is often challenging from both a medical and ethical prospective. Meticulous perinatal planning and parents' involvement is crucial. Endovascular embolization of the tumor feeding vessels can significantly improve the resection outcome and overall prognosis.


Subject(s)
Cesarean Section/methods , Embolization, Therapeutic/methods , Head and Neck Neoplasms/surgery , Teratoma/surgery , Tracheostomy/methods , Airway Obstruction , Female , Head and Neck Neoplasms/diagnosis , Head and Neck Neoplasms/embryology , Humans , Infant, Newborn , Intubation, Intratracheal/methods , Pregnancy , Prenatal Diagnosis , Teratoma/diagnosis , Teratoma/embryology , Treatment Outcome
2.
J Matern Fetal Neonatal Med ; 31(7): 914-918, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28277907

ABSTRACT

PURPOSE: The objectives of study were to assess and compare the effects of maternal hyperoxygenation on fetal circulation, in fetuses with intrauterine growth retardation and normal fetal growth. METHODS: Twelve singleton pregnant women with normal fetal growth and 12 singleton pregnant women with intrauterine growth restriction were recruited. Mean gestational age of 35.2 ± 3.5 and 34.7 ± 3.9 weeks, respectively. Doppler blood flow velocity waveforms were obtained from the middle cerebral artery, umbilical, main and proximal right pulmonary arteries. Pulsatility indices were calculated for all the vessels. Peak systolic velocity was determined for the middle cerebral artery. Following baseline measurements; each woman received 70% humidified oxygen for 10 min. Doppler measurements were then repeated. RESULTS: The pulsatility index in the middle cerebral artery increased significantly from 1.5 ± 0.27 to 1.88 ± 0.48, respectively (p = .006) in the high-risk group. However, it did not change significantly in the low-risk group. Hyperoxygenation caused a significant decrease in pulsatility indices in the pulmonary arteries for both groups. CONCLUSIONS: Hyperoxygenation interrupts the relative brain-sparing effect in the intrauterine growth retardation group, but it did not significantly change the pulsatility index of the middle cerebral artery in fetuses with adequate weight. The pulsatility index in the pulmonary arteries decreased significantly following hyperoxygenation.


Subject(s)
Blood Flow Velocity , Fetal Growth Retardation/physiopathology , Fetus/blood supply , Middle Cerebral Artery/embryology , Oxygen Inhalation Therapy , Case-Control Studies , Female , Fetal Development , Gestational Age , Hemodynamics , Humans , Middle Cerebral Artery/diagnostic imaging , Placenta/blood supply , Placenta/metabolism , Pregnancy , Ultrasonography, Prenatal
3.
Isr Med Assoc J ; 19(9): 543-546, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28971636

ABSTRACT

BACKGROUND: Management of postoperative pain has become a growing concern, even for minor gynecological procedures. Proper postoperative pain management has been shown to lead to earlier mobilization, shortened hospital stay, and increased patient satisfaction. The optimal means of reducing the pain of pregnancy termination has not yet been determined. OBJECTIVES: To compare the efficiency in pain management of two drugs, lornoxicam and paracetamol, given intravenously postoperatively to women who underwent abortion with dilation and curettage. METHODS: The cohort comprised 80 women scheduled for dilation and curettage for pregnancy termination at 6-12 gestational weeks. The anesthesiologist gave 1000 mg paracetamol or 20 mg lornoxicam soon after starting the procedure, according to a randomization table. The medical staff and the patients were blinded to the drug that was administered. Pain levels were evaluated by a 10 cm visual analogue scale (VAS) at 15, 30, 60, 90, and 120 minutes following arrival at the postoperative care unit. RESULTS: Mean levels of pain decreased from 60 minutes postoperative until the end of recording, reaching minimum levels at 120 minutes: 0.8 ± 0.19 and 1.5 ± 0.28, for lornoxicam and paracetamol, respectively. The differences between the groups were statistically significant (P < 0.05 from 60 minutes after the procedure until the time of discharge. CONCLUSIONS: Compared to women who received paracetamol, women who received lornoxicam after dilation and curettage for termination of pregnancy reported lower levels of pain, from 30 minutes postoperative until the time of discharge following the procedure.


Subject(s)
Abortion, Induced/adverse effects , Acetaminophen/therapeutic use , Dilatation and Curettage/adverse effects , Pain, Postoperative/drug therapy , Pain, Procedural/drug therapy , Piroxicam/analogs & derivatives , Abortion, Induced/methods , Female , Humans , Piroxicam/therapeutic use , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL